ELEGO
Live / Allowed — Fourth extension granted (statement of use) (as of 09 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 23 May 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98008461
- Mark type
- Word mark
- Filed
- 23 May 2023
- Published for opposition
- 22 Aug 2023
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for immunoglobulin therapy, the treatment and prevention of primary or secondary immunodeficiencies, autoimmune disease and disorders, blood and/or bleeding disorders and diseases; Pharmaceuticals for the treatment and prevention of blood and/or bleeding disorders; Blood products, namely, blood plasma, blood, and immunoglobulin for medical or therapeutic purposes; Blood proteins for therapeutic use
- Class 010 — Medical apparatus: Surgical and medical apparatus and instruments, namely, for the administration of subcutaneous therapy; medical devices for the administration of subcutaneous therapy
Owner
- CSL Limited, Parkville VIC, AU
- CSL Limited, Parkville VIC, AU
Board proceedings on this mark
- Extension of Time to Oppose No. 98008461 — LEGO Juris A/S v. CSL Limited, filed 20 Sept 2023 (Terminated)
Prosecution history
- 09 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 09 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Mar 2026 — SOU EXTENSION 4 GRANTED
- 09 Mar 2026 — SOU EXTENSION 4 FILED
- 09 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2025 — SOU EXTENSION 3 GRANTED
- 09 Sept 2025 — SOU EXTENSION 3 FILED
- 09 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Mar 2025 — SOU EXTENSION 2 GRANTED
- 10 Mar 2025 — SOU EXTENSION 2 FILED
- 10 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2024 — SOU EXTENSION 1 GRANTED